APA
Mossé Y. P., Lipsitz E., Fox E., Teachey D. T., Maris J. M., Weigel B., Adamson P. C., Ingle M. A., Ahern C. H. & Blaney S. M. (20130611). Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study. : Clinical cancer research : an official journal of the American Association for Cancer Research.
Chicago
Mossé Yael P, Lipsitz Emily, Fox Elizabeth, Teachey David T, Maris John M, Weigel Brenda, Adamson Peter C, Ingle Mark A, Ahern Charlotte H and Blaney Susan M. 20130611. Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study. : Clinical cancer research : an official journal of the American Association for Cancer Research.
Harvard
Mossé Y. P., Lipsitz E., Fox E., Teachey D. T., Maris J. M., Weigel B., Adamson P. C., Ingle M. A., Ahern C. H. and Blaney S. M. (20130611). Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study. : Clinical cancer research : an official journal of the American Association for Cancer Research.
MLA
Mossé Yael P, Lipsitz Emily, Fox Elizabeth, Teachey David T, Maris John M, Weigel Brenda, Adamson Peter C, Ingle Mark A, Ahern Charlotte H and Blaney Susan M. Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20130611.